Analysis of the CD47-SHPS-1 signaling system in autoimmune disease
Analysis of the CD47-SHPS-1 signaling system in autoimmune disease
批准号:
18591098
负责人:
KANEKO Yoriaki
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 (SHPS-1), which is originally identified as a substrate for protein tyrosine phosphatases SHP-1 and SHP-2, is a member of immunoglobulin superfamily. SHPS-1 contains ITIM in its intracellular domain and its extra-cellular region interacts with CD47, which is widely expressed on immune cells. The interaction between CD47 and SHPS-1 constitutes a cell-cell communication system (the CD47-SHPS-1 signaling system) that may function in regulation of a variety of biological responses. SHPS-1 is predominantly exposed on macrophages and dendritic cells (DCs), and the CD47-SHPS-1 signaling system is considered to be a negative regulator of immune responses. We investigated the physiological roles of SHPS-1 by the use of SHPS-1 mutant mice, which lack most of the cytoplasmic region of its protein and we revealed some important functions. SHPS-1 negatively regulates the phagocytosis of RBCs by splenic macrophages and it determines both the lifespan of individual RBCs and the number of circulating erythrocytes. SHPS-1 on DCs is essential for both priming of naive T cells and the activation of NKT cells. SHPS-1 positively regulates the development of autoimmune disease and α-GalCer-induced anti-metastatic activities. These results indicate the CD47-SHPS-1 signaling system plays important roles in immune responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.4049/jimmunol.178.10.6164
发表时间:
2007-05-15
期刊:
JOURNAL OF IMMUNOLOGY
影响因子:
4.4
作者:
[Okajo, Jun, Kaneko, Yoriaki, Nojima, Yoshihisa]
通讯作者:
Nojima, Yoshihisa
Enhanced phagocytosis of CD47-deficient red blood cells by spienic macrophages requires SHPS-1
精神巨噬细胞增强 CD47 缺陷红细胞的吞噬作用需要 SHPS-1
DOI:
--
发表时间:
2007
期刊:
Biochem Biophys Res Commun 343(4)
影响因子:
--
作者:
[Ishikawa-Sekigami T, Kaneko Y, et. al.]
通讯作者:
et. al.
Regulation by SHPS-1 of α-GalCer-induced antimetastatic activity and Th1 and Th2 responses of natural killer T cells.
SHPS-1 对 α-GalCer 诱导的抗转移活性以及自然杀伤 T 细胞的 Th1 和 Th2 反应的调节。
DOI:
--
发表时间:
2007
期刊:
J. Immunol. 178
影响因子:
--
作者:
[Okajo, J., et. al.]
通讯作者:
et. al.
DOI:
10.1016/j.bbrc.2008.04.124
发表时间:
2008-07-04
期刊:
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子:
3.1
作者:
[Okuzawa, Chie, Kaneko, Yoriaki, Nojima, Yoshihisa]
通讯作者:
Nojima, Yoshihisa
Resistance to experimental autoimmune encephalomyelitis and impaired T cell priming by dendritic cells in SHPS-1 mutant mice.
SHPS-1 突变小鼠中树突状细胞对实验性自身免疫性脑脊髓炎的抵抗力和 T 细胞启动受损。
DOI:
--
发表时间:
2007
期刊:
J. Immunol. 179
影响因子:
--
作者:
[Tomizawa, T., Kaneko, Y., Kaneko, Y., Saito, Y., Ohnishi, H., Okajo, J., Okuzawa, C., Ishikawa-Sekigami, T., Murata, Y., Okazawa, H., Okamoto, K., Nojima, Y. Matozaki, T.]
通讯作者:
T.
共 10 条
国内基金
海外基金
登录
查看更多内容
基于铁死亡与CD47固有免疫检查点的共递送纳米药物增强骨肉瘤免疫治疗的研究
-
批准号:2026JJ82540
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡欣
-
依托单位:
放射治疗诱导DLG1与CD47共表达促进乳腺肿瘤免疫逃逸
-
批准号:2026JJ60027
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:罗舒凤
-
依托单位:
血小板反应蛋白-1/CD47信号调控糖尿病视网膜病变炎症反应机制研究
-
批准号:2026JJ80372
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王会艳
-
依托单位:
hUC-MSCs来源的THBS2通过CD47/PPAR-α/GPX4通路抑制腺泡细胞铁死亡治疗急性胰腺炎的机制研究
-
批准号:2026JJ30203
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:黄耿文
-
依托单位:
携带CD47纳米抗体工程菌OMV-CD47nb与ICD肿瘤细胞仿生杂交膜纳米疫苗的构建及其抗癌效应研究初探
-
批准号:JCZRYB202500618
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基因工程化细胞膜囊泡递送丹参-川芎药对通过调控CD47/SIRPα信号通路抗炎防治心力衰竭的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:于 玲
-
依托单位:
靶向干预外泌体中免疫球蛋白超家族成员CD47抑制KRAS突变肺癌
发生骨转移的分子机制探究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李坤
-
依托单位:
激活型NO纳米报告器用于监测CD47抗体的疗效
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
基因工程改造的多能CD19-CART细胞通过外泌抗 CD47 scFv 增强抗肿瘤免疫的功能验证与机制探索
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:李玉华
-
依托单位:
N-糖基转移酶 MAN1B1 通过调控 CD47 促进
膀胱癌免疫逃逸机制研究
-
批准号:Y24H160082
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:余燕岚
-
依托单位: